Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions American Journal of Ophthalmology February 2020 Pubmed
Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months British Journal of Ophthalmology September 2019 Pubmed
Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months Ophthalmology Retina August 2019 Pubmed
Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! Project American Journal of Ophthalmology August 2019 Pubmed
Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study British Journal of Ophthalmology August 2019 Pubmed
Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents Ophthalmology May 2019 Pubmed
A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! Cohort Ophthalmology Retina March 2019 Pubmed
Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration Ophthalmology January 2019 Pubmed
Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational Study Retina October 2018 Pubmed
A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project Graefeās Archive for Clinical and Experimental Ophthalmology October 2018 Pubmed
Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project American Journal of Ophthalmology June 2018 Pubmed